CRYSVITA

Kyowa Kirin, Inc.🇨🇦 Health Canada

Approval Id: 036d625db055b15c
Drug Approval Canada Name: CRYSVITA
Product Name: CRYSVITA
Status: Marketed
Status Date: 2022-11-30
Original Market Date: 2019-01-28
Din: 02483629
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 40:92.00
Atc Original: M05BX05 BUROSUMAB
Atc Name: m 05 bx 05
Aig Number: 0160950001
Company Name: Kyowa Kirin, Inc.
Company Address: 510 Carnegie Center, Suite 600, Princeton, New Jersey, United States, 08540
Company Detail Path: /organization/kyowa-kirin-inc

BUROSUMAB

10 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

036d625db055b15c

Type

Standard